# Program 07 Cancer Epidemiology

> **NIH NIH P30** · DANA-FARBER CANCER INST · 2024 · $39,282

## Abstract

Cancer Epidemiology Program
Project Summary / Abstract
The mission of the Cancer Epidemiology Program (CEP) is to facilitate and conduct innovative epidemiology
research related to cancer and to support translation of the findings into meaningful advances in cancer
prevention, screening, diagnosis, and treatment. A key programmatic goal is the integration of cancer
epidemiology research across the Cancer Center’s disease- and discipline-based Programs. As a result, inter-
programmatic collaborations have led to the ‘forward translation’ of epidemiologic findings into prospective
clinical trials and ‘reverse translation’ to laboratory studies that explore the cellular and molecular mechanisms
underlying epidemiologic observations. The Program is deeply invested in the mission of training and
mentoring students and postdoctoral and clinical fellows who represent the next generation of cancer
epidemiologists, especially trainees from underrepresented minority backgrounds.
The Program’s 68 members (50 primary and 18 secondary) represent all seven DF/HCC institutions and 12
academic departments. In 2019, peer-reviewed grant funding attributed to the Program was $11.5 million in
direct costs from the NCI and $3.8 million from other sponsors. During the current funding period, primary CEP
members published 1,093 cancer-relevant papers. Of these, 47% were inter-institutional, 46% were intra-
programmatic and 40% were inter-programmatic collaborations between two or more DF/HCC members.
These numbers reflect the breadth of interactivity promoted by the CCSG structure and senior leaders.
Program members tackle etiological questions in cancer mortality, including lifestyle factors, as well as
predictive and prognostic biomarker studies. The Program emphasizes research goals in priority areas of our
catchment area, the DF/HCC strategic plan, and scientific focus outlined in the NCI’s 2022 Annual Plan
(obesity and cancer; cancer survivorship). For the next CCSG funding period, our Specific Aims are to
accelerate science, collaboration, translation, and training in the following areas: (1) Energy balance,
metabolism, and cancer; (2) Risk factors and cancer subtypes; (3) Molecular and genomic biomarkers in
cancer; and (4) Factors associated with cancer mortality.

## Key facts

- **NIH application ID:** 10768667
- **Project number:** 5P30CA006516-59
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** A. Heather Eliassen
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $39,282
- **Award type:** 5
- **Project period:** 1997-03-10 → 2026-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10768667

## Citation

> US National Institutes of Health, RePORTER application 10768667, Program 07 Cancer Epidemiology (5P30CA006516-59). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10768667. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*